ORLANDO, FL – Thermo Fisher Scientific Inc., the world leader in serving science, has announced the release of Thermo Scientific Momentum 3.2, the latest enhancement of the established Momentum™ scheduling software, for optimum automation control. Momentum 3.2 extends upon Momentum’s well-recognized efficiency to enable the seamless integration of workflows with maximum operator simplicity. The upgraded […]
Genea Stem Cells Pty Ltd (GSC), a supplier and developer of disease-specific human stem cells, today announced that 25 of its disease specific embryonic pluripotent stem cell lines have been placed on the USA National Institutes of Health (NIH) human stem cell registry. These embryonic stem cell lines are now all available commercially for use […]
IntelliCyt Corporation, a provider of assay screening solutions for phenotypic drug discovery, antibody discovery and in vitro toxicity testing, today announced the introduction of their new iQue™ Screener. The new system is the latest addition to IntelliCyt’s platform of instrumentation, application-specific reagents, integrated multi-user analysis and informatics tools. The iQue Screener will be unveiled tomorrow […]
In a challenging economy that compels wise purchasing decisions, AMRESCOhas increasingly become the supplier of choice for Life Sciences companies by virtue of the company’s solid reputation for quality and value. AMRESCO is a company committed to developing innovative life science products and custom solutions for companies and researchers around the world. More than three […]
PORT WASHINGTON, N.Y., – Pall Corporation (NYSE:PLL), a global leader in filtration, separation and purification, today announced that it has expanded its Menlo Park, California facility, the site of its ForteBio® operations, to create a Center of Excellence (COE) for Instrumentation. The expanded COE, located in the heart of the Silicon Valley/Bay area, occupies more […]
MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced today that the sale of its research and diagnostic antibody segment AbD Serotec to Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) has been completed. All assets and liabilities of the AbD Serotec segment of MorphoSys AG as well as all shares of the subsidiaries MorphoSys UK […]
In a paper published today in the journal PLOS ONE, a research team headed by Dr. Paul Wheeler from the Animal Healthand Veterinary Laboratories Agency (AHVLA, Weybridge, UK) reported breakthrough progress in understanding the metabolic and phenotypic properties of the bacterium Mycobacterium tuberculosis and its close relative, Mycobacterium bovis. Link to article: https://dx.plos.org/10.1371/journal.pone.0052673 Mycobacterum tuberculosis […]
ALAMEDA, Calif. —- LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the release of MalaCards version 1.02 on January 7. The new release is available at www.malacards.org. MalaCards is a new database of human diseases and their annotations that is modeled on the architecture and richness of the popular GeneCards® […]
St. Louis, Mo. —— Bio-Assembler Kits utilize magnetic levitation to culture cells in 3-D. Available in single, six and 24-well configurations, the kits supply magnetic drivers, low-binding dishes/plates, and Nanoshuttle-PL solution in quantities and volumes appropriate to kit size. Nanoshuttle-PL solution delivers magnetic nanoparticles to cells. The magnetic driver that nests on top of the […]
Welwyn Garden City, UK –– Cresset Group, innovative provider of chemistry software and services, announces that ProMining Therapeutics Ltd has chosen to license sparkV10 for assistance in its hit-to-lead optimization efforts. sparkV10 is Cresset’s desktop bioisostere software tool which is used by medicinal and computational chemists for drug design. “sparkV10 is an exciting and powerful […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
